The Diabetes-Cardiovascular Connection in Women: Understanding the Known Risks, Outcomes, and Implications for Care

Eric K Broni1, Chiadi E Ndumele1, Justin B Echouffo-Tcheugui2

  • 1Department of Medicine, Division of Cardiology, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Current Diabetes Reports
|February 14, 2022
PubMed

Insights

Women with diabetes face higher cardiovascular disease risks and poorer outcomes than men. Addressing gender disparities and utilizing advanced therapies like SGLT-2 inhibitors can improve outcomes for diabetic women.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Cardiovascular disease (CVD) is a major cause of mortality in people with diabetes.
  • Women with diabetes experience a disproportionately higher relative increase in CVD morbidity and mortality compared to men.
  • Existing gender disparities in social determinants of health and healthcare access exacerbate risks for women with diabetes.

Purpose of the Study:

  • To review recent evidence on the risks, outcomes, and management of cardiovascular disease in women with diabetes.
  • To highlight the unique challenges and disparities faced by women with diabetes concerning CVD.
  • To discuss implications for clinical practice and future research.

Main Methods:

  • Systematic review of recent scientific literature.
  • Analysis of epidemiological data on CVD in diabetic populations, stratified by gender.
  • Evaluation of clinical trial data and treatment guidelines.

Main Results:

  • Women with diabetes present with higher BMI and a more adverse cardiovascular risk profile at diagnosis.
  • They face increased risks for coronary heart disease, stroke, vascular dementia, and heart failure compared to men.
  • Pregnancy-specific conditions like gestational diabetes and pre-eclampsia are linked to future T2D and CVD.
  • Women with type 2 diabetes may benefit more from GLP-1 receptor agonists.
  • Poorer CVD outcomes in women are compounded by social determinants of health and lower access to interventions and trials.

Conclusions:

  • Women with diabetes face a greater relative risk of CVD complications and poorer outcomes than men.
  • Addressing gender-specific risks and disparities is crucial for effective CVD prevention and management.
  • Further research and the strategic use of SGLT-2 inhibitors, GLP-1 receptor agonists, and other cardioprotective strategies are essential to reduce morbidity and mortality in women with diabetes.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.1K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
898
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
216
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
428
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.5K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
44